FUJIFILM VisualSonics has introduced the Vevo F2 LAZR-X20, a photoacoustic imaging platform, now available for preclinical ultrasound applications.
The new system integrates high-powered laser technology to facilitate advanced tissue characterisation with precise anatomical accuracy in preclinical animal models.
FUJIFILM VisualSonics global high frequency vice president Greg Nesbitt said: “For more than two decades, FUJIFILM VisualSonics has been delivering ultra-high frequency ultrasound and photoacoustic imaging solutions to the scientific research community.
“As a leader in the space, we saw an opportunity to expand the scope of questions that can be answered using photoacoustics. The Vevo LAZR-X20 underscores our commitment to constantly innovating and bringing more applications and capabilities to a broader set of research domains.”
According to FUJIFILM VisualSonics, Vevo F2 LAZR-X20’s advanced laser technology offers improved imaging depth and real-time high-resolution capabilities. This allows researchers to visualise different tissue types and contrast agents using a unique wavelength range of 660-1320 nm.
Non-invasive detection of tissue chromophores such as lipids and collagen is possible due to their unique absorption profiles within this spectrum. This facilitates visualisation of tumour microenvironments and assessment of therapeutic efficiency.
FUJIFILM VisualSonics product innovation director Andrew Needles said: “This cutting-edge product represents a significant advancement in our portfolio, seamlessly integrating photoacoustics with ultrasound imaging into a single platform.
“The new system provides excellent image quality and an expanded spectral range, providing researchers with comprehensive data for their imaging studies. We believe this breakthrough technology will not only enhance current research capabilities but also has the potential to unlock new applications, particularly in the fields of oncology and neurobiology.”
The Vevo F2 LAZR-X20 system is designed for versatility, allowing users to adjust imaging depth and resolution as needed. It supports low-frequency imaging for improved depth (up to 9 cm) and ultra-high frequency for superior resolution (down to 30 microns).
The platform includes interchangeable fibre optics for specific light delivery applications and provides real-time oxygen saturation and molecular imaging co-registered with high-resolution anatomy.
